{"transactions":[{"id":720867,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2026-07-01T20:21:19.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Share options vest in twelve equal monthly installments commencing on July 29, 2026."}],"balance_after":47500,"derivative":{"exercise_price":1.61,"expiration_date":"2036-06-29","underlying":"American Depositary Shares","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001730463-26-000107","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000173046326000107/form4.xml","form_type":"4"}},{"id":720866,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true}}],"security":"Restricted Share Units","published_at":"2026-07-01T20:21:19.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."}],"balance_after":31667,"derivative":{"underlying":"American Depositary Shares","underlying_shares":31667},"source":{"system":"sec-edgar","filing":"0001730463-26-000107","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000173046326000107/form4.xml","form_type":"4"}},{"id":739838,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000062","document":"wk-form4_1781299452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000062/wk-form4_1781299452.xml","form_type":"4"}},{"id":739837,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":3269,"source":{"system":"sec-edgar","filing":"0001689548-26-000062","document":"wk-form4_1781299452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000062/wk-form4_1781299452.xml","form_type":"4"}},{"id":1100249,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T20:55:21.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":10520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 26, 2025."}],"balance_after":10520,"derivative":{"exercise_price":44.04,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":10520},"source":{"system":"sec-edgar","filing":"0001689548-25-000080","document":"wk-form4_1751057715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954825000080/wk-form4_1751057715.xml","form_type":"4"}},{"id":1488456,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T22:55:34.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":8566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024."}],"balance_after":8566,"derivative":{"exercise_price":44.25,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":8566},"source":{"system":"sec-edgar","filing":"0001689548-24-000075","document":"wk-form4_1717714526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954824000075/wk-form4_1717714526.xml","form_type":"4"}},{"id":1855939,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T11:13:29.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":28981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023."}],"balance_after":28981,"derivative":{"exercise_price":0.957,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":28981},"source":{"system":"sec-edgar","filing":"0001689548-23-000109","document":"wf-form4_168674119773018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954823000109/wf-form4_168674119773018.xml","form_type":"4"}},{"id":2253541,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:25:31.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":22753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022."}],"balance_after":22753,"derivative":{"exercise_price":8.38,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":22753},"source":{"system":"sec-edgar","filing":"0001689548-22-000064","document":"wf-form4_165368670859170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954822000064/wf-form4_165368670859170.xml","form_type":"4"}},{"id":2288645,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-04-29T01:34:22.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":28000,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001415889-22-004339","document":"form4-04282022_060430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000141588922004339/form4-04282022_060430.xml","form_type":"4"}},{"id":2288644,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-04-29T01:34:22.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":9852,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78010,"source":{"system":"sec-edgar","filing":"0001415889-22-004339","document":"form4-04282022_060430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000141588922004339/form4-04282022_060430.xml","form_type":"4"}},{"id":2639393,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T21:16:55.000Z","date":"2021-05-13","kind":"other","acquired":true,"shares":28473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Clarus Lifesciences III, L.P., of which the reporting person is a limited partner."}],"balance_after":28473,"source":{"system":"sec-edgar","filing":"0001689548-21-000069","document":"wf-form4_162569259680052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954821000069/wf-form4_162569259680052.xml","form_type":"4"}},{"id":2675730,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T21:03:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":22343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 8, 2021."}],"balance_after":22343,"derivative":{"exercise_price":20.42,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":22343},"source":{"system":"sec-edgar","filing":"0001689548-21-000060","document":"wf-form4_162327257160147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954821000060/wf-form4_162327257160147.xml","form_type":"4"}},{"id":2735651,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-04-29T22:14:51.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-21-004705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911021004705/edgar.xml","form_type":"4"}},{"id":2735650,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-29T22:14:51.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":9828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68158,"source":{"system":"sec-edgar","filing":"0001179110-21-004705","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911021004705/edgar.xml","form_type":"4"}},{"id":389769,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:38:17.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":4527,"derivative":{"exercise_price":286.27,"expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001209191-20-034055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034055/doc4.xml","form_type":"4"}},{"id":3166347,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-04-30T23:09:11.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-20-005307","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911020005307/edgar.xml","form_type":"4"}},{"id":3166346,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-04-30T23:09:11.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58330,"source":{"system":"sec-edgar","filing":"0001179110-20-005307","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911020005307/edgar.xml","form_type":"4"}},{"id":397084,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397083,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":100,"price":220.08,"value":22008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."}],"balance_after":9311,"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397082,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":10134,"price":219.37,"value":2223095.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.08 to $219.78)."}],"balance_after":9411,"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":7266,"price":218.73,"value":1589292.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $218.73 (range $218.08 to $219.07)."}],"balance_after":19545,"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397080,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":2500,"price":217.72,"value":544300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $217.72 (range $217.08 to $218.06)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":26811,"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:18:52.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":20000,"price":72.14,"value":1442800.0,"ownership":{"direct":true},"balance_after":29311,"source":{"system":"sec-edgar","filing":"0001209191-20-001775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120001775/doc4.xml","form_type":"4"}},{"id":397555,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":65.65,"expiration_date":"2024-05-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":397554,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":300,"price":221.16,"value":66348.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $221.16 (range $221.09 to $221.30)."}],"balance_after":9311,"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":397553,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":500,"price":220.25,"value":110125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $220.25 (range $219.90 to $220.73)."}],"balance_after":9611,"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":397552,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":21798,"price":218.93,"value":4772236.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.50 to $219.47)."}],"balance_after":10111,"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":397551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":7402,"price":218.05,"value":1614006.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $218.05 (range $217.50 to $218.49)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":31909,"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":397550,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:21:28.000Z","date":"2019-12-30","kind":"exercise","acquired":true,"shares":30000,"price":65.65,"value":1969500.0,"ownership":{"direct":true},"balance_after":39311,"source":{"system":"sec-edgar","filing":"0001209191-20-000298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120000298/doc4.xml","form_type":"4"}},{"id":402536,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:19:00.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":2381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":9311,"source":{"system":"sec-edgar","filing":"0001209191-19-034251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034251/doc4.xml","form_type":"4"}},{"id":3542111,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T22:36:22.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005472","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911019005472/edgar.xml","form_type":"4"}},{"id":3542110,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T22:36:22.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51695,"source":{"system":"sec-edgar","filing":"0001179110-19-005472","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911019005472/edgar.xml","form_type":"4"}},{"id":414317,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T20:30:21.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":3229,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":3229},"source":{"system":"sec-edgar","filing":"0001209191-18-035701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035701/doc4.xml","form_type":"4"}},{"id":414316,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T20:30:21.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":6930,"source":{"system":"sec-edgar","filing":"0001209191-18-035701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035701/doc4.xml","form_type":"4"}},{"id":3947074,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T22:20:48.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006197","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911018006197/edgar.xml","form_type":"4"}},{"id":3947073,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T22:20:48.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43310,"source":{"system":"sec-edgar","filing":"0001179110-18-006197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911018006197/edgar.xml","form_type":"4"}},{"id":425795,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T22:02:46.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":5295,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0001209191-17-037916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037916/doc4.xml","form_type":"4"}},{"id":425794,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T22:02:46.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5129,"source":{"system":"sec-edgar","filing":"0001209191-17-037916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037916/doc4.xml","form_type":"4"}},{"id":4313311,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T22:05:45.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35124,"source":{"system":"sec-edgar","filing":"0001179110-17-007547","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217420/000117911017007547/edgar.xml","form_type":"4"}},{"id":437630,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-06-03T21:10:48.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":7073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":7073,"derivative":{"exercise_price":93.51,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":7073},"source":{"system":"sec-edgar","filing":"0001209191-16-125727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116125727/doc4.xml","form_type":"4"}},{"id":437629,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-06-03T21:10:48.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":2941,"price":0.01,"value":29.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests on the first anniversary of the grant date."}],"balance_after":2941,"source":{"system":"sec-edgar","filing":"0001209191-16-125727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116125727/doc4.xml","form_type":"4"}},{"id":450026,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2015-06-03T20:51:13.000Z","date":"2015-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":127.54,"exercise_date":"2015-06-01","expiration_date":"2025-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-15-049660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919115049660/doc4.xml","form_type":"4"}},{"id":464394,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2014-06-03T20:17:30.000Z","date":"2014-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":72.14,"exercise_date":"2014-06-01","expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-14-038675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114038675/doc4.xml","form_type":"4"}},{"id":465104,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2014-05-09T20:09:41.000Z","date":"2014-05-07","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 05/07/2014."}],"balance_after":30000,"derivative":{"exercise_price":65.65,"expiration_date":"2024-05-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-14-032611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114032611/doc4.xml","form_type":"4"}}]}